Trial Profile
Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms OPERA
- 18 Apr 2017 Status changed from active, no longer recruiting to completed.
- 10 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Feb 2017.
- 14 Mar 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016, according to ClinicalTrials.gov record.